Feature Channels: AIDS and HIV

Filters close
Released: 5-Dec-2023 7:05 AM EST
Dose matters: HIV drug could prevent coronaviruses, study finds
University of Bristol

New research by the University of Bristol has shown how an HIV drug could stop many coronavirus diseases, including the SARS-CoV-2 variants, when given to infected cells at the right concentration. The findings could strengthen the arsenal of antiviral drugs available to combat current and future coronavirus outbreaks.

Not for public release

This news release is embargoed until 1-Dec-2023 5:05 AM EST Released to reporters: 24-Nov-2023 10:05 AM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2023 5:05 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: November Research Highlights
Released: 30-Nov-2023 11:05 AM EST
November Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
Released: 29-Nov-2023 8:00 AM EST
Eradicating HIV Will Take Collaborative Action and a Commitment to Curb TB Infections
American Thoracic Society (ATS)

The COVID-19 pandemic hampered progress in fighting tuberculosis infections worldwide. Diverted funds meant that one of the world’s leading infectious killers caused 1.3 million deaths in 2022. TB is also the leading cause of death among those with HIV /AIDS worldwide. In 2022, 167,000 people died of HIV-associated TB.

Released: 28-Nov-2023 12:05 PM EST
Ending the HIV Epidemic May Require Addressing “Everyday” Discrimination
Rutgers University-New Brunswick

Latino sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic, according to a new Rutgers study.

   

Not for public release

This news release is embargoed until 27-Nov-2023 5:00 PM EST Released to reporters: 20-Nov-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 27-Nov-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 22-Nov-2023 12:05 PM EST
World AIDS Day: How Far We’ve Come and Where We Still Need to Go
Rutgers University-New Brunswick

Jeffrey Kwong, a professor at the Rutgers School of Nursing and a national HIV expert discusses the progress made and the challenges to overcome in ending AIDS by 2030.

Released: 22-Nov-2023 9:05 AM EST
Fighting AIDS: Why the goal is to diagnose HIV before symptoms appear
Mayo Clinic

HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome), can hide in the body for many years before symptoms appear.

Released: 22-Nov-2023 9:05 AM EST
A luta contra a AIDS: por que é importante detectar o HIV antes que os sintomas apareçam
Mayo Clinic

O HIV (vírus da imunodeficiência humana) que causa a AIDS (síndrome de imunodeficiência adquirida) pode ficar oculto no corpo por muitos anos antes da manifestação dos sintomas.

Released: 22-Nov-2023 9:05 AM EST
La lucha contra el SIDA: por qué el objetivo es detectar el VIH antes de que aparezcan los síntomas
Mayo Clinic

El VIH (virus de la inmunodeficiencia humana), el virus que causa el SIDA (síndrome de inmunodeficiencia adquirida), se puede esconder en el organismo durante muchos años antes de que aparezcan los síntomas.

Released: 22-Nov-2023 1:05 AM EST
مكافحة مرض نقص المناعة البشري المكتسب (الإيدز): لماذا يكمن هدفنا في اكتشاف فيروس نقص المناعة البشري قبل ظهور الأعراض
Mayo Clinic

روتشستر، مينيسوتا – إن فيروس نقص المناعة البشري، الذي يسبب الإيدز (مرض نقص المناعة البشري المكتسب) بإمكانه أن يختفي في الجسم عدة سنوات قبلما تظهر الأعراض. وخلال هذا الوقت، فإنه يقضي على جزء من الجهاز المناعي دون أن نشعر. لذا فإن هدفنا هو اكتشاف فيروس نقص المناعة البشري قبلما تظهر الأعراض، مما يجعل الاختبارات الروتينية ضروريةً كي يعرف المرضى أنهم مصابون وكي يتسنى علاجهم، وهذا ما أوضحته الدكتورة ستيسي ريزا خبيرة الأمراض المُعدية والباحثة في فيروس نقص المناعة البشري لدى مايو كلينك.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Released: 15-Nov-2023 3:05 AM EST
Another step toward the HIV-1 vaccine: Dynamics of neutralizing antibodies
University of Cologne

An international team has for the first time researched the longevity of neutralizing antibodies in HIV-1-infected people. Currently, it is assumed that an HIV-1 vaccine can only be effective if it produces these antibodies in vaccinated humans.

Newswise:Video Embedded what-you-need-to-know-taking-doxycycline-for-safer-sex
VIDEO
Released: 2-Nov-2023 11:05 AM EDT
What You Need to Know: Taking Doxycycline for Safer Sex
Cedars-Sinai

As the number of sexually transmitted infections (STIs) sharply rises in the U.S., new evidence suggests that a common antibiotic—doxycycline—could help prevent the spread of some bacterial infections.

Newswise: NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
Released: 2-Nov-2023 6:00 AM EDT
NIH grants support UCLA and Charles Drew University researchers' efforts to end HIV epidemic
University of California, Los Angeles (UCLA), Health Sciences

The National Institutes of Health (NIH) has granted $2.1 million to UCLA’s Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) and the UCLA-CDU Center for AIDS Research (CFAR) to support four research projects and an implementation science consultation hub.

Newswise: Fiber, the Gut, Heart Disease and HIV
Released: 1-Nov-2023 7:05 PM EDT
Fiber, the Gut, Heart Disease and HIV
Cedars-Sinai

Investigators from Cedars-Sinai have made two important discoveries about fiber and the gut microbiome in patients with human immunodeficiency virus, or HIV.

Released: 1-Nov-2023 4:05 PM EDT
Pet ownership may contribute to health care barriers for people with HIV
University of Florida

People living with HIV may face hard choices when balancing their own health needs with caring for a pet, a study led by a University of Florida College of Public Health and Health Professions researcher finds.

Newswise: Integrated chronic care in Africa can improve outcomes and save money
Released: 9-Oct-2023 5:05 AM EDT
Integrated chronic care in Africa can improve outcomes and save money
La Trobe University

Across Africa about two million premature deaths each year are caused by the effects of diabetes and hypertension.

Newswise: $2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
Released: 5-Oct-2023 5:05 PM EDT
$2.9M NIH grant awarded to Cizik School of Nursing researcher to fund real-time HIV prevention and substance use reduction strategies
University of Texas Health Science Center at Houston

A four-year, $2.9 million grant to assess the implementation of real-time health intervention to decrease substance use and support HIV prevention strategies in young adults experiencing homelessness.

Released: 3-Oct-2023 6:05 AM EDT
Pharmacists can improve access to life-saving vaccines
University of Waterloo

HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.

Released: 27-Sep-2023 12:50 PM EDT
Stay informed on women's health issues in the Women's Health channel
Newswise

Below are some of the latest headlines in the Women's Health channel on Newswise.

Newswise: Discovery highlights need for new approach to STI vaccine
Released: 19-Sep-2023 12:05 PM EDT
Discovery highlights need for new approach to STI vaccine
University of Delaware

University of Delaware researchers conducted exhaustive studies of human papillomavirus (HPV), the most common sexually transmitted infection (STI) in the world. They confirmed 25 different types of HPV prevalent in Nigeria, a discovery that underscores the need for more region-specific vaccines.

Released: 13-Sep-2023 2:05 PM EDT
Studies on Mobile Health Intervention Suggest Positive Impact for Black Same Gender–Loving Men
Rutgers University-New Brunswick

The mobile application, iTHRIVE 365, is the first of its kind to provide psychological health resources, connections to economic support and a safe social space created by and for Black gay, bisexual and other same gender–loving men.

Released: 12-Sep-2023 10:05 AM EDT
Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV
Mount Sinai Health System

The National Cancer Institute has awarded the Icahn School of Medicine at Mount Sinai a $3.4 million grant to create a model that identifies the best prostate cancer treatment for people with HIV.

Released: 12-Sep-2023 10:05 AM EDT
HIV: two autopsies reveal where the virus hides
Universite de Montreal

A research team shows for the first time that HIV reservoirs are concentrated in the spleen and lymph nodes, and that they can travel throughout the body.

Released: 6-Sep-2023 10:30 AM EDT
Beauty salon–based intervention increases trust of PrEP among Black cisgender women
Wolters Kluwer Health: Lippincott

Among African American and other Black cisgender women, a beauty salon–based intervention improved knowledge and awareness of pre-exposure prophylaxis (PrEP) against HIV and increased trust in it.

Released: 17-Aug-2023 10:00 AM EDT
Moffitt Awarded $5.5 Million to Study Virus-Associated Tumors Among Those Living with HIV in Sub-Saharan Africa
Moffitt Cancer Center

The Center for Immunization and Infection Research in Cancer at Moffitt Cancer Center is expanding its viral infection research in Africa. The cancer center has received a $5.5 million, five-year specialized research center grant (U54CA277834) from the National Cancer Institute to investigate virus-associated tumors that disproportionately impact men and women living with HIV in sub-Saharan Africa.

Released: 16-Aug-2023 1:10 PM EDT
Racism, Poverty, and Illiteracy Increase the Risk of Contracting and Succumbing to AIDS in Brazil
Barcelona Institute for Global Health, ISGlobal

Social determinants of health —the social conditions in which people grow up, live and work— can influence the risk of contracting AIDS and the mortality associated with the disease.

   
Newswise: Can Better Data Predict Opioid Overdoses and Slow Infectious Disease Rates?
Released: 10-Aug-2023 2:50 PM EDT
Can Better Data Predict Opioid Overdoses and Slow Infectious Disease Rates?
Tufts University

Tufts University School of Medicine teams and collaborators are running multiple projects that seek to reduce overdoses and the spread of infections, such as HIV and hepatitis C, in people who use drugs

Newswise:Video Embedded traditional-healers-in-rural-mpumalanga-help-diagnose-hiv
VIDEO
Released: 10-Aug-2023 8:55 AM EDT
Traditional healers in rural Mpumalanga help diagnose HIV
University of the Witwatersrand, Johannesburg

An initiative of Wits University’s MRC/Wits Agincourt Research Unit, the Traditional Healers Project convened two ‘open houses’ at local primary healthcare facilities – Rolle Clinic and Thulamahashe Community Health Centre in rural Bushbuckridge, Mpumalanga – in March 2023.

Released: 8-Aug-2023 4:05 PM EDT
تقليل خطورة العَدوى المنقولة جنسيًا
Mayo Clinic

العَدوى المنقولة جنسيًا (الأمراض المنقولة جنسيًا) آخذة في الارتفاع في الولايات المتحدة وحول العالم. ذكرت منظمة الصحة العالمية أن أكثر من مليون إصابة جديدة من العَدوى المنقولة جنسيًا تحدث يوميًا - معظمها بدون أعراض.

Released: 8-Aug-2023 3:05 PM EDT
Redução dos riscos de doenças sexualmente transmissíveis
Mayo Clinic

As doenças sexualmente transmissíveis (DSTs) continuam a aumentar nos EUA e ao redor do mundo. A Organização Mundial da Saúde relata que mais de 1 milhão de novas doenças sexualmente transmissíveis são adquiridas diariamente, sendo que a maioria delas é assintomática.

Released: 8-Aug-2023 3:05 PM EDT
Reducir los riesgos de infecciones de trasmisión sexual
Mayo Clinic

Las infecciones de trasmisión sexual (ITS) siguen aumentando en los EE. UU. al igual que en el resto del mundo. Según la Organización Mundial de la Salud, hay más de un millón de nuevas infecciones de trasmisión sexual al día, la mayoría de las cuales son asintomáticas.

Newswise: Gut Microbiome Can Increase Risk, Severity of HIV, EBV Disease
Released: 7-Aug-2023 12:30 PM EDT
Gut Microbiome Can Increase Risk, Severity of HIV, EBV Disease
University of North Carolina School of Medicine

UNC School of Medicine researchers Angela Wahl, PhD, Balfour Sartor MD, J. Victor Garcia, PhD, and colleagues created a germ-free mouse model to evaluate the role of the microbiome in the infection, replication, and pathogenesis of HIV and the Epstein-Barr virus, the virus that can cause mononucleosis and other serious diseases.

31-Jul-2023 12:05 PM EDT
Genetic variant linked to lower levels of HIV virus in people of African ancestry
University of Cambridge

An international team of researchers has found a genetic variant that may explain why some people of African ancestry have naturally lower viral loads of HIV, reducing their risk of transmitting the virus and slowing progress of their own illness.

Newswise: HIV patients can safely undergo hip replacement, study finds
Released: 26-Jul-2023 10:45 AM EDT
HIV patients can safely undergo hip replacement, study finds
UT Southwestern Medical Center

Hip replacement surgery is safe for patients living with human immunodeficiency virus (HIV), researchers at UT Southwestern Medical Center found.

Newswise: Study Shows Positive Outcomes for First Three U.S. Living HIV-To-HIV Kidney Transplant Donors
Released: 24-Jul-2023 12:55 PM EDT
Study Shows Positive Outcomes for First Three U.S. Living HIV-To-HIV Kidney Transplant Donors
Johns Hopkins Medicine

Based on findings from a study published today in the journal, The Lancet Regional Health – Americas, researchers at Johns Hopkins Medicine and three collaborating medical institutions suggest that people living with the human immunodeficiency virus (HIV) who donate a kidney to other people living with HIV (PLWH) have a low risk of developing end-stage kidney disease (ESKD) or other kidney problems in the years following the donation.

Newswise: New Community Partnership Model Boosts Inclusion of Participants into HIV Cure-Directed Research
Released: 19-Jul-2023 12:05 PM EDT
New Community Partnership Model Boosts Inclusion of Participants into HIV Cure-Directed Research
Wistar Institute

Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now, Wistar Institute researchers are sharing how a more inclusive model for community engagement can lead to deeper insights and greater community participation in HIV research.

   
Released: 14-Jul-2023 11:55 AM EDT
Gender, race and socioeconomic status are associated with comorbidity in people with HIV who smoke
Wolters Kluwer Health: Lippincott

High rates of smoking among people with HIV are associated with high rates of comorbid health problems – which are associated with characteristics including gender, race/ethnicity, and socioeconomic status, according to a study in the July issue of The Journal of the Association of Nurses in AIDS Care (JANAC). The official journal of the Association of Nurses in AIDS Care, JANAC is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: Preclinical Studies Led by Johns Hopkins Medicine Researchers Advance Potential New Target to Treat HIV Infection
Released: 6-Jul-2023 12:05 PM EDT
Preclinical Studies Led by Johns Hopkins Medicine Researchers Advance Potential New Target to Treat HIV Infection
Johns Hopkins Medicine

Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme that plays a critical role in the late stages of HIV replication.

Released: 5-Jul-2023 4:35 PM EDT
Global efforts to reduce infectious diseases must extend beyond early childhood
Murdoch Childrens Research Institute

Global efforts to reduce infectious disease rates must have a greater focus on older children and adolescents after a shift in disease burden onto this demographic, according to a new study.

Not for public release

This news release is embargoed until 3-Jul-2023 5:00 PM EDT Released to reporters: 27-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 3-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Wistar Honors Pediatric HIV Researcher in 27th Annual Jonathan Lax Memorial Award Lecture
Released: 22-Jun-2023 10:00 AM EDT
Wistar Honors Pediatric HIV Researcher in 27th Annual Jonathan Lax Memorial Award Lecture
Wistar Institute

Wistar hosts its 27th Jonathan Lax Memorial Lecture Thursday, June 29th at 5:30 pm EST.

Released: 19-Jun-2023 12:05 PM EDT
Scientists use Argonne supercomputer to detail HIV protein mechanism crucial for drug development
Argonne National Laboratory

Researchers from the University of Illinois Chicago used the Theta supercomputer at the Argonne Leadership Computing Facility to run simulations on and determine the molecular mechanisms behind the ways that new HIV antivirals could work.

   
Newswise: New Research Shows HIV Can Lie Dormant in the Brain
Released: 16-Jun-2023 2:30 PM EDT
New Research Shows HIV Can Lie Dormant in the Brain
University of North Carolina School of Medicine

New research published in the Journal of Clinical Investigations confirms that microglial cells – which are specialized immune cells with a decade-long lifespan in the brain - can serve as a stable viral reservoir for latent HIV.



close
2.57479